(Total Views: 432)
Posted On: 09/16/2019 12:50:42 PM
Post# of 58

$CLRB News Article - Cellectar Presents Data from Cohort 6 of its CLR 131 Phase 1 Study in Patients with Relapsed or Refractory Multiple Myeloma https://marketwirenews.com/news-releases/cell...01745.html


My Twitter: WhyteStocks